Magnesium Sulphate to Bupivicaine in Serratus Anterior Plane Block in Modified Radical Mastectomy

• Status: Recruiting
• Trial end date: 2020-10-01
• Target enrollment: 0
• Participant gender: Female

Summary

Modified radical mastectomy may be associated with severe post-operative pain, leading to chronic pain syndrome which usually requires optimal perioperative pain management.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alexandria University
• Treatments: Bupivacaine; Magnesium Sulfate

Criteria

Inclusion Criteria:

• adult female patients

• American Society Of Anesthesiologists (ASA) class I or II

• scheduled for elective unilateral modified radical mastectomy

Exclusion Criteria

• patient refusal

• bilateral breast surgery

• coagulation disorders

• body mass index> 35

• allergy to local anaesthetics or magnesium sulphate

• severe respiratory or cardiac disorders

• pre-existing neurological deficits

• liver or renal insufficiency